Evaluation of the therapeutic potential of masitinib and expression of its specific targets <scp>c‐Kit</scp> , <scp>PDGFR</scp> ‐α, <scp>PDGFR</scp> ‐β, and Lyn in canine prostate cancer cell lines-Reference-Cited by-同舟云学术

Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit , PDGFR ‐α, PDGFR ‐β, and Lyn in canine prostate cancer cell lines

Published:2022-04-09 Issue:3 Volume:20 Page:641-652
ISSN:1476-5810
Container-title:Veterinary and Comparative Oncology
language:en
Short-container-title:Vet Comparative Oncology

Author:

Klose Katharina¹,Packeiser Eva‐Maria¹,Granados‐Soler José‐Luis¹,Hewicker‐Trautwein Marion²,Murua Escobar Hugo³,Nolte Ingo¹

Affiliation:

1. Small Animal Clinic University of Veterinary Medicine Hannover, Foundation Hannover Germany

2. Department of Pathology University of Veterinary Medicine Hannover Hannover Germany

3. Division of Medicine Clinic III, Hematology, Oncology and Palliative Medicine University of Rostock Rostock Germany

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vco.12817

Reference73 articles.

1. Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs

2. Prostate cancer in dogs: Comparative and clinical aspects

3. Alterations in PTEN, MDM2, TP53 and AR protein and gene expression are associated with canine prostate carcinogenesis

4. Review of Animal Models of Prostate Cancer Bone Metastasis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD117 expression in canine ovarian tumours;Journal of Comparative Pathology;2024-07

2. Resistance of prostate cancer to kinase inhibitors;Therapy Resistance in Prostate Cancer;2024

3. Cancer drugs with high repositioning potential for Alzheimer’s disease;Expert Opinion on Emerging Drugs;2023-10-02

4. MDR1 Inhibition Reverses Doxorubicin-Resistance in Six Doxorubicin-Resistant Canine Prostate and Bladder Cancer Cell Lines;International Journal of Molecular Sciences;2023-05-02

5. c-kit inhibitor masitinib induces reactive oxygen species-dependent apoptosis in c-kit-negative HepG2 cells;European Journal of Pharmacology;2022-09